Eva-Lotta Allan

Eva-Lotta has more than 30 years’ experience in the healthcare industry. During this time, she has been a Senior Executive and Board member at both public and private companies. Most recently, Eva-Lotta was Chief Business Officer (and previously a Board member) at Immunocore, where she held full responsibility for all aspects of business development and played an instrumental role in the $320 million fundraising in 2015. Prior to this, Eva-Lotta served as Chief Business Officer and member of the Executive Committee and Euronext IPO team for Ablynx NV. Eva-Lotta currently serves as Non-Executive Director and Member of the Corporate Governance Committee and the R&D Sub-Committee of Oslo listed company, Targovax ASA and is a Non-Executive Director of Crescendo Biologics. Until earlier this year, Eva-Lotta was also a Board Member of the UK BioIndustry Association (BIA).